Follow
Carolyn Hoban
Carolyn Hoban
MGH Cancer Center
Verified email at mgh.harvard.edu
Title
Cited by
Cited by
Year
The SIF binding element confers sis/PDGF inducibility onto the c‐fos promoter.
BJ Wagner, TE Hayes, CJ Hoban, BH Cochran
The EMBO journal 9 (13), 4477-4484, 1990
7311990
Epinephrine-induced changes in the distribution of lymphocyte subsets in peripheral blood of humans.
B Crary, SL Hauser, M Borysenko, I Kutz, C Hoban, KA Ault, HL Weiner, ...
Journal of immunology (Baltimore, Md.: 1950) 131 (3), 1178-1181, 1983
3531983
The neuregulin, glial growth factor 2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis
B Cannella, CJ Hoban, YL Gao, R Garcia-Arenas, D Lawson, ...
Proceedings of the National Academy of Sciences 95 (17), 10100-10105, 1998
1911998
Immunohistochemical staining of human brain with monoclonal antibodies that identify lymphocytes, monocytes, and the Ia antigen
SL Hauser, AK Bhan, FH Gilles, CJ Hoban, EL Reinherz, SF Schlossman, ...
Journal of neuroimmunology 5 (2), 197-205, 1983
1731983
Immunoregulatory T‐cells and lymphocytotoxic antibodies in active multiple sclerosis: Weekly analysis over a six‐month period
SL Hauser, EL Reinherz, CJ Hoban, SF Schlossman, HL Weiner
Annals of Neurology: Official Journal of the American Neurological …, 1983
1031983
CSF cells in multiple sclerosis: Monoclonal antibody analysis and relationship to peripheral blood T‐cell subsets
SL Hauser, EL Reinherz, CJ Hoban, SF Schlossman, HL Weiner
Neurology 33 (5), 575-575, 1983
971983
Neuregulin in neuron/glial interactions in the central nervous system: GGF2 diminishes autoimmune demyelination, promotes oligodendrocyte progenitor expansion, and enhances …
MA Marchionni, C Hoban, R Garcia-Arenas, D Lawson, E Happel, ...
The Functional Roles of Glial Cells in Health and Disease: Dialogue between …, 1999
671999
Platelet‐derived growth factor stimulates rapid polyphosphoinositide breakdown in fetal human fibroblasts
SHW Chu, CJ Hoban, AJ Owen, RP Geyer
Journal of cellular physiology 124 (3), 391-396, 1985
571985
Neuregulins as potential drugs for neurological disorders
MA Marchionni, CJ Kirk, IJ Isaacs, CJ Hoban, NK Mahanthappa, ES Anton, ...
Cold Spring Harbor symposia on quantitative biology 61, 459-472, 1996
311996
Prioritization in comparative effectiveness research: the CANCERGEN Experience
R Thariani, W Wong, JJ Carlson, L Garrison, S Ramsey, PA Deverka, ...
Medical care 50 (5), 388-393, 2012
212012
Increased IgG secretion by unstimulated mononuclear cells in active multiple sclerosis and functional assessment of the T8 subset
SL Hauser, KA Ault, D Johnson, C Hoban, HL Weiner
Clinical immunology and immunopathology 37 (3), 312-323, 1985
91985
Increased spontaneous IgG production by cultured mononuclear cells in multiple sclerosis
SL Hauser, CJ Hoban, EL Reinherz, HL Weiner
Neurology 33 (Suppl 2), 180, 1983
51983
From the lab to the clinic: integration of pharmacogenics into clinical development
CJ Hoban
Pharmacogenomics 3 (4), 429-436, 2002
42002
The multiple myeloma research foundation (MMRF) commpassSM study: A longitudinal study in newly-diagnosed multiple myeloma patients to assess genomic profiles, immunophenotypes …
MN Needle, B Harrison, C Hoban, PG Kidd, S Jewell, T Monroe, JJ Keats, ...
Blood 120 (21), 3980, 2012
32012
SWOG Cooperative Group biorepository resource: access for scientific research studies
CJ Hoban, W Franklin, KJ Kopecky, LH Baker
Clinical Cancer Research 17 (16), 5239-5246, 2011
32011
Recent advances in preclinical drug development in multiple sclerosis
CJ Hoban
Expert Opinion on Therapeutic Patents 8 (7), 831-854, 1998
21998
Neuregulin in neuron/glial interactions in the central nervous system
MA Marehionni, B Cannella, C Hoban
GGF2 diminishes autoimmune demyelination, promotes oligodendro-cyte …, 1999
11999
The MMRF CoMMpassSM Study: A prospective, longitudinal, multicenter observational study in newly diagnosed multiple myeloma patients to assess the relationship between patient …
CJ Hoban, P Kidd, S Jewell, T Monroe, S Khoo, D Rohrer, J Levy, ...
Cancer Research 72 (8_Supplement), 4561-4561, 2012
2012
PCN82 RESEARCH PRIORITIZATION FOR PROSPECTIVE COMPARATIVE EFFECTIVENESS RESEARCH (CER) IN CANCER GENOMICS
D Veenstra, R Thariani, JJ Carlson, L Garrison, P Mohr, P Deverka, ...
Value in Health 7 (13), A266, 2010
2010
Activation index of IGF-IR in sarcoma subtypes
C Hoban, D Thomas, D Lev, R Pollock, L Baker
Cancer Research 68 (9_Supplement), 2192-2192, 2008
2008
The system can't perform the operation now. Try again later.
Articles 1–20